BETRF (BetterLife Pharma) Total Payout Ratio: 0.14 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BETRF BetterLife Pharma Inc BETRF
16 GF Score
Price $0.21
! 3 Warning Signs
View Full Analysis

What is BetterLife Pharma Total Payout Ratio?

BetterLife Pharma BETRF +18.34% 16 Total Payout Ratio is 0.14 as of Aug. 01, 2026. GuruFocus rates BETRF with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

BetterLife Pharma's current Total Payout Ratio is 0.14.

BetterLife Pharma Total Payout Ratio Related Terms

BetterLife Pharma Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for BetterLife Pharma's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BetterLife Pharma Total Payout Ratio Chart

BetterLife Pharma Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.09 0.76 0.20 0.00

BetterLife Pharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.42

BETRF vs VRTX, REGN, RVMD: Total Payout Ratio Comparison

For the Biotechnology subindustry, BetterLife Pharma's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BetterLife Pharma Total Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BetterLife Pharma's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where BetterLife Pharma's Total Payout Ratio falls into.


BETRF
16GF Score
BetterLife Pharma Inc BETRF
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BetterLife Pharma Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

BetterLife Pharma's Total Payout Ratio for the fiscal year that ended in Jan. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -1.099
=0.00

BetterLife Pharma's Total Payout Ratio for the quarter that ended in Apr. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0.188 + 0) / -0.446
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.14 mean?
BetterLife Pharma (BETRF) has a Total Payout Ratio of 0.14 as of Aug. 01, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on BetterLife Pharma and its competitors.
Is BetterLife Pharma's Total Payout Ratio too high?
BetterLife Pharma's current Total Payout Ratio is 0.14. Overall, BetterLife Pharma has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does BetterLife Pharma's Total Payout Ratio compare to VRTX and REGN?
BetterLife Pharma's Total Payout Ratio of 0.14 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Biotechnology company?
A good Total Payout Ratio depends on the Biotechnology industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on BetterLife Pharma and its competitors. BetterLife Pharma's current Total Payout Ratio is 0.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BetterLife Pharma stock overvalued right now?
BetterLife Pharma (BETRF) has a current Total Payout Ratio of 0.14. The current Total Payout Ratio is 0.14. BetterLife Pharma's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For BetterLife Pharma (BETRF), the current Total Payout Ratio is 0.14 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BetterLife Pharma Business Description

Other Exchanges NPAU:GermanyBETR:Canada
Address 1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc is a biopharmaceutical company engaged in the development of patented pharmaceuticals. It is an emerging biotechnology company mainly focused on developing compounds for the treatment of mental disorders. It is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight viral infections. The Company operates in one industry segment, development and commercialization of patented pharmaceuticals within one geographical area.
16GF Score

Get the complete analysis for BETRF

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price